Delivery Order SPE2DR25D7009-SPE2DR26F8MRD
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order contract on August 21, 2025, for the supply of Praziquantel 600 mg tablets in quantities of six units, with a ceiling value of $6,032.66. The contract is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and is performed from the company's Conshohocken, Pennsylvania location. This award carries no set-aside designation and was competitively awarded through the Defense Logistics Agency's Medical Supply...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Praziquantel 600 mg tablets in a quantity of 6 units, with a contract ceiling value of $4,520.45. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 2, 2025. The performance location is established at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for Praziquantel 600 mg tablets (quantity 6) valued at $1,273.76. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the agency's pharmaceutical procurement framework. The order is set to be completed by July 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Praziquantel 600 mg tablets. The firm-fixed-price contract has a ceiling value of $2,744.10 and a period of performance through February 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Praziquantel 600 mg tablets on September 9, 2025. This firm fixed-price delivery order, valued at $2,771.45, has an ultimate completion date of September 10, 2025, and represents a non-competitive award under an existing contract vehicle. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,783.45 for Praziquantel 600 mg tablets (quantity of 6 units) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Praziquantel tablets with a ceiling value of $1,063.72. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Praziquantel 600 mg tablets in a quantity of six units, valued at $1,256.28. This firm fixed-price delivery order, with a completion date of August 14, 2025, represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Praziquantel is an antiparasitic medication commonly used in...
- This delivery order, awarded on August 21, 2025, provides Praziquantel 600 mg tablets (6-count) to the Defense Department's Medical Supply Chain through AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract carries a ceiling value of $5,417.11 under a firm fixed-price arrangement with an ultimate completion date of August 22, 2025. This award represents a non-competitive delivery order issued under AmerisourceBergen's broader...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Praziquantel 600 mg tablets, a medication used to treat certain parasitic infections. The contract has a ceiling value of $2,066.81 and is a firm fixed-price contract. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate...
- SPE2DR25D7009Indefinite Delivery Contract
- SPE2DR25D7009-SPE2DR26F8MRDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,940.94 to AmerisourceBergen Drug Corp for the supply of Praziquantel 600 mg tablets in quantities of six units. This competitive, non-set-aside contract award was issued on January 26, 2026, with a completion date of January 27, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract utilizes firm fixed-price pricing structure, typical of delivery orders issued under larger indefinite delivery contract vehicles. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal military healthcare systems and supplies an extensive range of medications, vaccines, and medical devices to support Department of Defense healthcare requirements globally. The company's federal contracting history demonstrates consistent capability to fulfill competitive pharmaceutical procurement across multiple therapeutic domains serving military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/25/26 |